1. Home
  2. BMRN vs HRL Comparison

BMRN vs HRL Comparison

Compare BMRN & HRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$58.97

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Logo Hormel Foods Corporation

HRL

Hormel Foods Corporation

HOLD

Current Price

$25.01

Market Cap

11.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMRN
HRL
Founded
1996
1891
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Meat/Poultry/Fish
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
11.8B
IPO Year
1999
1994

Fundamental Metrics

Financial Performance
Metric
BMRN
HRL
Price
$58.97
$25.01
Analyst Decision
Buy
Buy
Analyst Count
18
6
Target Price
$88.22
$26.50
AVG Volume (30 Days)
1.9M
3.9M
Earning Date
05-04-2026
05-28-2026
Dividend Yield
N/A
5.61%
EPS Growth
N/A
N/A
EPS
0.54
0.62
Revenue
$1,313,646,000.00
$12,106,160,000.00
Revenue This Year
$15.02
$2.66
Revenue Next Year
$12.23
$1.62
P/E Ratio
$109.20
$40.33
Revenue Growth
17.62
1.55
52 Week Low
$49.26
$19.72
52 Week High
$66.28
$30.28

Technical Indicators

Market Signals
Indicator
BMRN
HRL
Relative Strength Index (RSI) 61.76 58.49
Support Level $53.32 $24.08
Resistance Level $61.92 $25.23
Average True Range (ATR) 1.49 0.57
MACD 0.19 -0.08
Stochastic Oscillator 85.48 40.45

Price Performance

Historical Comparison
BMRN
HRL

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About HRL Hormel Foods Corporation

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (5.9%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.

Share on Social Networks: